Lonza primary, diseased primary and stem cells
Research shows that non-transformed, non-immortalised cells isolated directly from tissue provide conditions that closely simulate a living model and yield more physiologically significant results.
With Clonetics Primary Normal Cells and Media, Lonza provides over 150 authenticated primary human and animal cell types with optimised media for growth and maintenance.
With Clonetics Primary Diseased Cells, the company offers primary cells derived from patients with COPD, asthma, Type 1 and Type 2 diabetes.
The company’s Stem Cells and Media offer primary human adult stem and progenitor cells from bone marrow, cord blood and adipose tissue with growth and differentiation media, and ES-derived differentiated cells and media.
Lonza primary cells and media are tested together to guarantee performance. The company uses strict industry QC standards to ensure consistent performance on every lot manufactured.
All tissue utilised for the company’s human cell products is ethically obtained with documented and informed donor consent.
Phone: 03 9550 0883
The platform helps to overcome lentiviral production challenges and can reduce process...
Diaclone provides a large panel of research tools, monoclonal antibodies and ELISA kits for...
BioLamina's Biosilk is a 3D cell culture biomaterial made from recombinant spider silk...